MAPK pathway as a target for therapy in melanoma.

Units : Laboratory of Oncology and Experimental Surgery | ULB305

Description :

The project investigates new machanisms to overcome MAPK pathway inhibitors in BRAF or NRAS mutated melanomas.

List of persons in charge :

  • GHANEM Ghanem Elias

  • JOURNE Fabrice

List of lessors :

  • Télévie

  • Entreprises privées